Sinecod Cough Sedative 3mg / 10g Syrup 200ml
- Brand: GLAXOSMITHKLINE C.HEALTH.Srl
- Product Code: 021483146
- Availability: In Stock
- Purchase 3 items for 5.87€ each
- Purchase 4 items for 5.75€ each
- Purchase 5 items for 5.63€ each
Sinecod syrup Dry cough Sedative 3mg / 10g
Sinecod scirtoppo is a sedative of cough, thanks to its active ingredients has a fluidizing action that frees the airways and reduces cough, this can be caused by multiple factors such as allergies and irritations caused by permanence in dry environments, irritations caused by environments in which you smoke or are polluted, bacteria, asthma
Active ingredients contained in sinecod dry cough syrup
SINECOD TOSSE SEDATIVO 2 mg / ml oral drops, solution 1 g of solution (equal to 20 drops) contains: Active ingredient: butamirate citrate 2 mg (equal to butamirate 1,3 mg approx.). Excipients with known effects: ethanol 96 percent, glycerol, methyl parahydroxybenzoate, sucrose. SINECOD TOSSE SEDATIVO 3 mg / 10 g syrup 100 g of syrup contain: Active ingredient: butamirate citrate g 0.0345 (equivalent to butamirate mg 21.3 ca). Excipients with known effects: ethanol, glycerol, methyl parahydroxybenzoate, sorbitol. SINECOD TOSSE SEDATIVO 5 mg tablets One tablet contains: Active ingredient: butamirate citrate 5 mg (equivalent to butamirate 3.1 mg). For a full list of excipients, see section 6.1.
SINECOD TOSSE SEDATIVO 2 mg / ml oral drops, Glycerol solution; sucrose; anethole; vanillin; ethanol 96 percent; methyl parahydroxybenzoate; purified water. SINECOD TOSSE SEDATIVO 3 mg / 10 g syrup Citric acid; glycerol; sorbitol; anethole; vanillin; methyl parahydroxybenzoate; ethanol; purified water. SINECOD TOSSE SEDATIVO 5 mg Isomalt tablets; mint essence; levomenthol; potassium acesulfame; neohesperidin dihydrocalcone; mixture of vegetable oils and fats and corn starch.
Contraindications in the use of Sinecod cough syrup
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Sinecod Cough Sedative tablets: children under the age of 12. Sinecod Cough Sedative syrup and drops: children under the age of 6 years.
Posology and methods of use
SINECOD TOSSE SEDATIVO sugar-free tablets: Adults: 1 tablet every 6 hours (as a maximum dose, 1 tablet every 4 hours, it is possible to use two tablets consecutively at bedtime, in order to have a longer effect at night). Boys (over 12 years): 1 tablet every 12 hours. The tablets should be sucked or chewed in the mouth. SINECOD TOSSE SEDATIVO drops: School-age children (6-12 years): 20 drops every 8-6 hours. Adults: 40 drops every 6-5 hours. The drops should be administered in a little water or milk. SINECOD TOSSE SEDATIVO syrup: School-age children (6-12 years): 10 ml every 8-6 hours. Adults: 15 ml every 8-6 hours. Wash and dry the measuring cup after each use and after use between different patients. Do not exceed the recommended dose. Prolonged use of cough sedatives is not justified. Treatment will be limited to the symptomatic period. If the cough persists for more than 7 days, in the presence of fever, dyspnoea or chest pain, the doctor should be consulted. Pediatric population: Sinecod Cough Sedative tablets are contraindicated in children younger than 12 years (see section 4.3 Contraindications). Sinecod Cough Sedative syrup and Sinecod Cough Sedative drops is contraindicated in children younger than 6 years (see section 4.3 Contraindications)
Warnings and precautions
Because of the inhibition of cough reflex by butamirate, concomitant use with expectorants should be avoided because it may cause mucus stagnation in the airways with increased risk of bronchospasm and respiratory tract infection. In patients with severe renal and / or hepatic impairment, Sinecod Cough Sedative should only be administered if it is actually needed and under the physician's direct control, taking into account that effective plasma butamirate citrate rates may be higher and / or longer lasting. in subjects with normal hepatic and / or renal function. SINECOD TOSSE SEDATIVO 2 mg / ml oral drops, solution contains: • ETHANOL: this medicinal product contains small amounts of ethanol (about 0.54%,). Each dose contains up to about 0.095 g of alcohol. It is harmful for those suffering from liver disease, alcoholism, epilepsy, brain disorders as well as for pregnant women and children. It can modify or enhance the effects of other drugs. • GLYCEROL: it is harmful in high doses. May cause headaches, gastric disorders and diarrhea. • PARAIDROSSIBENZOATI AND THEIR ESTERS: it is known that they can cause urticaria. In general it can cause delayed type reactions such as contact dermatitis; rarely immediate reactions with urticaria and bronchospasm. • Sacchario: This medicinal product contains approximately 19.5 g / 100 ml of sugar (sucrose). If taken according to the recommended dosage each dose (15 drops) provides about 0.13 g of sugar (sucrose). Patients with rare hereditary problems of fructose intolerance, from glucose malabsorption. or insufficiency of sucrase isomaltase, should not take this medicine. SINECOD TOSSE SEDATIVO 3 mg / 10 g SYRUP contains • ETHANOL: attention this medicine contains small amounts of ethanol (about 0.47%). Each dose contains up to about 0.07 g of alcohol. It is harmful for those suffering from liver disease, alcoholism, epilepsy, brain disorders as well as for pregnant women and children. It can modify or enhance the effects of other drugs. • GLYCEROL: it is harmful in high doses. May cause headaches, gastric disorders and diarrhea. • PARAIDROSSIBENZOATI AND THEIR ESTERS: it is known that they can cause urticaria. In general they can cause delayed type reactions such as contact dermatitis; rarely immediate reactions with urticaria and bronchospasm. • SORBITOL: this medicinal product contains approximately 40.7 g / 100 ml of sorbitol. When taken according to the recommended dosage each dose (5 ml) provides about 2 g of sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. May cause stomach upset and diarrhea.
No specific interactions studies have been conducted. Concomitant use with expectorants should be avoided (see section 4.4).
Adverse reactions are listed below, based on the classification by organ systems and frequency. The frequencies are defined as: very common (≥ 1/10); common (≥1 / 100, <1/10); uncommon (≥1 / 1,000, <1/100); rare (≥ 1 / 10,000; <1 / 1,000); very rare (<1 / 10,000); not known (frequency can not be defined based on available data) Within each frequency class, adverse reactions are reported in order of decreasing severity. Nervous system disorders Rare: drowsiness, dizziness. Gastrointestinal disorders Rare: nausea, diarrhea Skin and subcutaneous tissue disorders Rare: urticaria Immune system disorders Not known: hypersensitivity reactions Reporting of suspected adverse reactions Reporting of suspected adverse reactions occurring after authorization of the medicinal product is important, in as it allows a continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it/it/responsabili.
Pregnancy and breastfeeding
Safety of use during pregnancy and lactation has not been evaluated in specific studies. The use of Sinecod Cough Sedative should be avoided during the first three months of pregnancy. During the rest of pregnancy Sinecod Cough Sedative should only be used if it is strictly necessary. It is not known whether the active substance and / or one of its metabolites are excreted in human milk. For safety reasons, as a general rule, before taking Sinecod Cough Sedative during lactation, the risks and benefits should be carefully considered.